Business & Finance
Anti-infectives-focused biotech company reports Q4, year end 2004 results
Published in AIDS Vaccine Week, March 28th, 2005
For the 4th quarter of 2004, Vitex reported a net loss of $7.2 million or $0.13 per share versus a net loss of $2.7 million or $0.07 per share for the 4th quarter of 2003. Revenue from research funding increased from $0.4 million in the 4th quarter of 2003 to $1.2 million in the 4th quarter of 2004, reflecting the recognition into revenue of approximately $0.8 million in previously deferred revenue relating to nonrefundable up-front and milestone payments from Amersham Pharmacia...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Vaccine Week
Source: AIDS Vaccine Week (2005-03-28)
More Articles from AIDS Vaccine Week
- Cognition
Nef neurotoxicity associated with cognitive deficits in HIV infection - HIV/AIDS Vaccine
DermaVir is a new topical vaccine for HIV/AIDS - HIV/AIDS Vaccine
E-communications company teams with U2's Bono to combat AIDS, poverty in Africa - HIV/AIDS Vaccine
HIV genomic RNA sequences in female genital tract and blood reported - HIV/AIDS-Associated Disorder
Acquired rectal fistula may be sign of HIV infection in children - AIDS Funding
U.S. HHS awards almost $1.7 billion for HIV/AIDS care - More from this issue of AIDS Vaccine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
